Crinetics Pharmaceuticals, Inc. (CRNX) NASDAQ
32.61
-1.91(-5.53%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
32.61
-1.91(-5.53%)
Currency In USD
| Market Cap | 4.38B |
| Enterprise Value | 4.33B |
| P/E Ratio | -6.84 |
| PEG Ratio | 0.25 |
| Price/Sales Ratio | 190.29 |
| Price/Book Ratio | 2.65 |
| Enterprise/Revenue | 186.61 |
| Enterprise/EBITDA | -6.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -27.47 |
| Operating Margin | -30.2 |
| Return On Assets | -0.35 |
| Return On Equity | -0.44 |
| Revenue | 7.7M |
| Revenue/Share | 0.17 |
| Gross Profit | 6.62M |
| EBITDA | -512.88M |
| Net Income | -465.32M |
| Diluted EPS | -4.95 |
| Total Cash | 1.29B |
| Total Cash/Share | 12.4 |
| Total Debt | 47.86M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 18.6 |
| Book Value Per Share | 12.3 |
| 52-Week Change | 1.59 |
| 52-Week High | 57.99 |
| 52-Week Low | 25.83 |
| Moving Average 50 Days | 37.68 |
| Moving Average 200 Days | 41.5 |
| Average Volume | 1.21M |
| Shares Outstanding | 105.44M |
| % Held by Institutions | 130.53 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |